Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness, Immunogenicity and Safety of the Second Booster Dose (Fourth Dose) of the Vaccine Against COVID-19 in the Elderly: Study Reforça Mais (Plus Booster)

NCT05283902 is registered in ClinicalTrials.gov with Federal University of Espirito Santo as lead sponsor.

NCT NCT05283902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05283902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness, Immunogenicity and Safety of the Second Booster Dose (Fourth Dose) of the Vaccine Against COVID-19 in the Elderly: Study Reforça Mais (Plus Booster)
Lead sponsor
Federal University of Espirito Santo
Phase
Observational
Overall status
Completed
Start date
March 19, 2022
Completion date
October 1, 2022
Enrollment
260 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, vaccine adverse reaction, vaccine-preventable diseases